NFKB1 and COVID-19: Monocyte-derived macrophages are involved in lung and multiorgan inflammation observed in severe COVID-19 patients [110,111,112] which necessitate the investigation of potential natural phenolic compounds that could reduce NF-κB activation and inhibit the production of proinflammatory cytokines and chemokines by macrophages.